secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2021-09-20T23:59:59+00:00
Accession:  0001193125-21-277335
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte appoints Annie Drapeau and Teri Loxam to board; Heron and Hopfner resign
--------------------------------------------------------------------------------

- Directors Patrick Heron and Rob Hopfner resigned effective Sept 16, 2021, not due to any disagreement.
- Annie Drapeau and Teri Loxam appointed as Class I directors with terms expiring at 2024 annual meeting.
- Drapeau joins Compensation and Nominating Committees; Loxam joins Audit Committee.
- Each new director receives initial option for 30,000 shares vesting over 3 years, annual option for 15,000 shares, and cash retainers ($40,000 base plus committee fees).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312521277335/0001193125-21-277335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312521277335/d234071d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-277335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer